Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank40
3Y CAGR-37.5%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-37.5%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
202420.87%
202340.17%
202261.58%
202185.31%
20200.00%
20190.00%